Strekin AG Secures CHF 10 Million Financing for Further Development of STR001 in Sudden Hearing Loss
– Strekin AG, a Swiss clinical stage biopharmaceutical company, announced today that it has successfully closed a Seed C financing round totaling CHF10 million from…